Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc.Financial_Report.xls
EX-32.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3202.htm
EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3102.htm
EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex3101.htm
EX-10.1 - CONSULTING AGREEMENT - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex1001.htm
10-Q - FORM 10-Q - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-093012.htm
EX-10.2 - STOCK UNIT AGREEMENT - Brooklyn ImmunoTherapeutics, Inc.ntn_10q-ex1002.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-Q for the period ended September 30, 2012 (the “Report”), I, Jeff Berg, Interim Chief Executive Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

   
Dated: November 9, 2012 /s/ Jeff Berg 
  Jeff Berg
  Interim Chief Executive Officer
  NTN Buzztime, Inc.